In the US, Atovaquone (atovaquone systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Babesiosis, Malaria, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis and Toxoplasmosis.
US matches:
- Atovaquone
- Atovaquone/Proguanil
- Atovaquone and proguanil
- Atovaquone and chloroguanide
- Atovaquone and Proguanil Hydrochloride
- Atovaquone/Proguanil Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P01AX06
CAS registry number (Chemical Abstracts Service)
0095233-18-4
Chemical Formula
C22-H19-Cl-O3
Molecular Weight
366
Therapeutic Category
Antiprotozoal
Chemical Name
Naphthoquinone, 2-[trans-4-(p-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-
Foreign Names
- Atovaquonum (Latin)
- Atovaquon (German)
- Atovaquone (French)
- Atovacuona (Spanish)
Generic Names
- Atovaquone (OS: USAN, BAN, DCF)
- 566C (IS: Burroughs Wellcome)
- 566C80 (IS: Burroughs Wellcome)
- Compound 566 (IS: Burroughs Wellcome)
- Atovaquone (PH: USP 32)
Brand Names
- Malarone (Atovaquone and Proguanil)
Dr. Fisher, Netherlands; Eureco, Netherlands; Glaxo SmithKline, Spain; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, United States - Malarone Junior (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden - Malarone Paediatric (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece - Melanil (Atovaquone and Proguanil)
GlaxoSmithKline, South Africa - Mepron
GlaxoSmithKline, Canada; GlaxoSmithKline, United States - Wellvone
Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa; Wellcome-GB, Italy
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment